Medical Exoskeleton

Medical Exoskeleton

Global Medical Exoskeleton Market to Reach $2.8 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Medical Exoskeleton estimated at US$284.8 Million in the year 2020, is projected to reach a revised size of US$2.8 Billion by 2027, growing at aCAGR of 38.7% over the period 2020-2027. Hardware, one of the segments analyzed in the report, is projected to record 34.2% CAGR and reach US$1.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Software segment is readjusted to a revised 44.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $83.3 Million, While China is Forecast to Grow at 36.6% CAGR

The Medical Exoskeleton market in the U.S. is estimated at US$83.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$455.3 Million by the year 2027 trailing a CAGR of 36.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 35.3% and 32.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 24.6% CAGR.

Select Competitors (Total 34 Featured) -

  • Bionik Laboratories Corp
  • B-TEMIA Inc.
  • Cyberdyne Inc.
  • Ekso Bionics Holdings, Inc.
  • ExoAtlet
  • Gogoa Mobility Robots SL
  • Hocoma AG (A Subsidiary of DIH Technologies)
  • Parker Hannifin Corp
  • ReWalk Robotics Ltd
  • Rex Bionics Ltd.
  • Tyromotion GmbH
  • US Bionics
  • Wearable Robotics SRL
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Medical Exoskeleton – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Medical Exoskeleton by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Medical Exoskeleton by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Medical Exoskeleton by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Powered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Powered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Powered by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Passive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for Mobile by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Mobile by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Mobile by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 19: World Recent Past, Current & Future Analysis for Stationary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Stationary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Stationary by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 22: World Medical Exoskeleton Market Analysis of Annual Sales in US$ for Years 2012 through 2027
III. MARKET ANALYSIS
UNITED STATES
Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 23: USA Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 24: USA Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 25: USA 15-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2021 & 2027
TABLE 26: USA Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 27: USA Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 28: USA 15-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2021 & 2027
TABLE 29: USA Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 30: USA Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 31: USA 15-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2021 & 2027
CANADA
TABLE 32: Canada Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 33: Canada Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 34: Canada 15-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2021 & 2027
TABLE 35: Canada Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 36: Canada Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 37: Canada 15-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2021 & 2027
TABLE 38: Canada Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 39: Canada Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 40: Canada 15-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2021 & 2027
JAPAN
Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 41: Japan Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 42: Japan Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 43: Japan 15-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2021 & 2027
TABLE 44: Japan Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 45: Japan Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 46: Japan 15-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2021 & 2027
TABLE 47: Japan Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 48: Japan Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 49: Japan 15-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2021 & 2027
CHINA
Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 50: China Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 51: China Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 52: China 15-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2021 & 2027
TABLE 53: China Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 54: China Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 55: China 15-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2021 & 2027
TABLE 56: China Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 57: China Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 58: China 15-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2021 & 2027
EUROPE
Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 59: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
TABLE 60: Europe Historic Review for Medical Exoskeleton by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 61: Europe 15-Year Perspective for Medical Exoskeleton by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
TABLE 62: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 63: Europe Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 64: Europe 15-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2021 & 2027
TABLE 65: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 66: Europe Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 67: Europe 15-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2021 & 2027
TABLE 68: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 69: Europe Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 70: Europe 15-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2021 & 2027
FRANCE
Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 71: France Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 72: France Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 73: France 15-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2021 & 2027
TABLE 74: France Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 75: France Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 76: France 15-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2021 & 2027
TABLE 77: France Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 78: France Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 79: France 15-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2021 & 2027
GERMANY
Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 80: Germany Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 81: Germany Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 82: Germany 15-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2021 & 2027
TABLE 83: Germany Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 84: Germany Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 85: Germany 15-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2021 & 2027
TABLE 86: Germany Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 87: Germany Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 88: Germany 15-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2021 & 2027
ITALY
TABLE 89: Italy Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 90: Italy Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 91: Italy 15-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2021 & 2027
TABLE 92: Italy Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 93: Italy Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 94: Italy 15-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2021 & 2027
TABLE 95: Italy Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 96: Italy Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 97: Italy 15-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2021 & 2027
UNITED KINGDOM
Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 98: UK Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 99: UK Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 100: UK 15-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2021 & 2027
TABLE 101: UK Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 102: UK Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 103: UK 15-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2021 & 2027
TABLE 104: UK Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 105: UK Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 106: UK 15-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 108: Rest of Europe Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 109: Rest of Europe 15-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2021 & 2027
TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 111: Rest of Europe Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 112: Rest of Europe 15-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2021 & 2027
TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 114: Rest of Europe Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 115: Rest of Europe 15-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 117: Asia-Pacific Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 118: Asia-Pacific 15-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2021 & 2027
TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 120: Asia-Pacific Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 121: Asia-Pacific 15-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2021 & 2027
TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 123: Asia-Pacific Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 124: Asia-Pacific 15-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2021 & 2027
REST OF WORLD
TABLE 125: Rest of World Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 126: Rest of World Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 127: Rest of World 15-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2021 & 2027
TABLE 128: Rest of World Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 129: Rest of World Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 130: Rest of World 15-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2021 & 2027
TABLE 131: Rest of World Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
TABLE 132: Rest of World Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
TABLE 133: Rest of World 15-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2021 & 2027
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings